Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Gentile

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
Preliminary Validation of a Cursive Handwriting Reconstruction Algorithm from a Sensorized Ink PenSimone Toffoli, Chiara Gentile, Linda Greta Dui, et al.
Iscience|August 13, 2025
TGF-β and IL-12 conversely orchestrate the formation of CD103<sup>+</sup> CD8 tumor-resident memory T cells to regulate response to therapeutic cancer vaccineStéphanie Corgnac, Isabelle Damei, Chiara Gentile, et al.
Vaccine|July 17, 2007
Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?Valeria Alfonsi, Emanuele Montomoli, Ilaria Manini, et al.
International Journal of Molecular Sciences|December 24, 2021
Generation of a Retargeted Oncolytic <i>Herpes</i> Virus Encoding Adenosine Deaminase for Tumor Adenosine ClearanceChiara Gentile, Arianna Finizio, Guendalina Froechlich, et al.
Cancers|August 13, 2020
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK CellsMargherita Passariello, Cinzia Vetrei, Emanuele Sasso, et al.
Scientific Reports|May 27, 2021
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2Margherita Passariello, Chiara Gentile, Veronica Ferrucci, et al.
Scientific Reports|March 11, 2020
Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysisEmanuele Sasso, Guendalina Froechlich, Gabriella Cotugno, et al.
Hepatology (Baltimore, Md.)|February 4, 2020
Characterizing Hepatitis C Virus-Specific CD4<sup>+</sup> T Cells Following Viral-Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral CureFelicity Hartnell, Ilaria Esposito, Leo Swadling, et al.
Communications Medicine|July 23, 2025
Cross-sectional entomological data reveals an increased risk of arboviral transmission in a year of record-breaking heat in Southern EuropeChiara Virgillito, Eleonora Longo, Carlo Maria De Marco, et al.
International Journal of Molecular Sciences|January 9, 2021
Generation of a Novel Mesothelin-Targeted Oncolytic <i>Herpes</i> Virus and Implemented Strategies for ManufacturingGuendalina Froechlich, Chiara Gentile, Luigia Infante, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
Preliminary Validation of a Cursive Handwriting Reconstruction Algorithm from a Sensorized Ink PenSimone Toffoli, Chiara Gentile, Linda Greta Dui, et al.
Iscience|August 13, 2025
TGF-β and IL-12 conversely orchestrate the formation of CD103<sup>+</sup> CD8 tumor-resident memory T cells to regulate response to therapeutic cancer vaccineStéphanie Corgnac, Isabelle Damei, Chiara Gentile, et al.
Vaccine|July 17, 2007
Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?Valeria Alfonsi, Emanuele Montomoli, Ilaria Manini, et al.
International Journal of Molecular Sciences|December 24, 2021
Generation of a Retargeted Oncolytic <i>Herpes</i> Virus Encoding Adenosine Deaminase for Tumor Adenosine ClearanceChiara Gentile, Arianna Finizio, Guendalina Froechlich, et al.
Cancers|August 13, 2020
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK CellsMargherita Passariello, Cinzia Vetrei, Emanuele Sasso, et al.
Scientific Reports|May 27, 2021
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2Margherita Passariello, Chiara Gentile, Veronica Ferrucci, et al.
Scientific Reports|March 11, 2020
Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysisEmanuele Sasso, Guendalina Froechlich, Gabriella Cotugno, et al.
Hepatology (Baltimore, Md.)|February 4, 2020
Characterizing Hepatitis C Virus-Specific CD4<sup>+</sup> T Cells Following Viral-Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral CureFelicity Hartnell, Ilaria Esposito, Leo Swadling, et al.
Communications Medicine|July 23, 2025
Cross-sectional entomological data reveals an increased risk of arboviral transmission in a year of record-breaking heat in Southern EuropeChiara Virgillito, Eleonora Longo, Carlo Maria De Marco, et al.
International Journal of Molecular Sciences|January 9, 2021
Generation of a Novel Mesothelin-Targeted Oncolytic <i>Herpes</i> Virus and Implemented Strategies for ManufacturingGuendalina Froechlich, Chiara Gentile, Luigia Infante, et al.
Pageof 2